Delivery Order SPE2DB22D1106-SPE2DB25FEYQ7
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $48K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 mL syringes. The $3,304.70 fixed-price delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to procure a wide range of medical commodities from Amerisourcebergen. This delivery order does not have a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Dupixent 300 mg/2 ml syringes. The $34,837.21 award has an ultimate completion date of March 29, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $14,937.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the procurement of 4,564,110,516 units of the pharmaceutical product Dupixent 300 mg/2 ml Syringe (2 ml). The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and with a performance period through December 31, 2025....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml syringes. The order, valued at $10,387.04, will support military treatment programs and facilities through March 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $24,419.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml syringes and has a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The U.S. Department of Defense's Medical Supply Chain (DLA Troop Support Medical) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Dupixent 300 mg/2 ml syringes. The order has a ceiling value of $3,342.10 and an ultimate completion date of May 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order valued at $10,777.92 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 300 mg/2 ml syringes. The contract, valued at $23,211.99, has an ultimate completion date of June 7, 2022. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $34,699.56 to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the supply of Dupixent 300 mg/2 ml syringes and has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Dupixent 300 mg/2 ml syringes. The $6,407.20 firm fixed-price contract has a completion date of July 8, 2024. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which enables the agency to efficiently procure a range of pharmaceutical products and...